设为首页 加入收藏

TOP

NORMACOL PLUS Granules.SterculiaFrangula
2014-12-12 19:17:30 来源: 作者: 【 】 浏览:600次 评论:0
Table of Contents
1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
4.1 Therapeutic indications
4.2 Posology and method of administration
4.3 Contraindications
4.4 Special warnings and precautions for use
4.6 Pregnancy and lactation
4.7 Effects on ability to drive and use machines
4.8 Undesirable effects
4.9 Overdose
5. PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
5.2 Pharmacokinetic properties
5.3 Preclinical safety data
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
6.2 Incompatibilities
6.3 Shelf life
6.4 Special precautions for storage
6.5 Nature and contents of container
6.6 Special precautions for disposal and other handling
7. MARKETING AUTHORISATION HOLDER
8. MARKETING AUTHORISATION NUMBER(S)
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
10. DATE OF REVISION OF THE TEXT

1. NAME OF THE MEDICINAL PRODUCT

 

NORMACOL PLUS Granules.

 

 

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

 

Each gram of Normacol Plus Granules contains 0.62g (62% w/w) of Sterculia and 0.08g (8% w/e) of Frangula.

Each sachet contains 4.34g of Sterculia and 0.56g of Frangula

For excipients, see 6.1

 

 

3. PHARMACEUTICAL FORM

 

Granules.

Brown irregular shaped granules with a slight odour and taste of peppermint.

 

 

4. CLINICAL PARTICULARS

     

4.1 Therapeutic indications

 

The treatment of constipation.

The initiation and maintenance of bowel action after rectal surgery and after haemorrhoidectomy.

 

 

4.2 Posology and method of administration

 

Adults (including the elderly): 1 or 2 sachets or 1-2 heaped 5ml

spoonfuls, once or twice daily after meals.

Children (6-12 years): A reduced amount may be given at the discretion of the physician.

The granules should be placed dry on the tongue and, without chewing or crushing, swallowed immediately with plenty of water or a cool drink Prior to drinking they may also be sprinkled on, and taken with soft food such as yoghurt.

 

4.3 Contraindications

 

Intestinal obstruction, faecal impaction, and total atony of the colon.

Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency.

Use in patients with a sensitivity to sterculia or frangula.

 

 

4.4 Special warnings and precautions for use

 

Caution should be exercised in the use of NORMACOL PLUS in cases of ulcerative colitis. Patients should be advised to maintain an adequate fluid intake, to avoid taking NORMACOL PLUS immediately before going to bed (especially if they are elderly), and to suspend treatment of bowel movements do not occur within four days.

 

 

4.5 Interaction with other medicinal products and other forms of interaction

 

None known.

 

 

4.6 Pregnancy and lactation

 

Pregnancy: No teratogenic effects have been reported, but caution should be exercised during the first trimester.

Lactation: There is no evidence to suggest that NORMACOL PLUS is unsuitable for use.

NORMACOL (Sterculia alone) is available if required in pregnancy and lactation.

 

 

4.7 Effects on ability to drive and use machines

 

None known.

 

 

4.8 Undesirable effects

 

Abdominal distension may occur. Oesophageal obstruction is possible if the product is not adequately washed down with fluid.

 

 

4.9 Overdose

 

Intestinal obstruction is possible in overdosage particularly in combination with inadequate fluid intake. Management is as for intestinal obstruction from other causes.

 

 

5. PHARMACOLOGICAL PROPERTIES

     

5.1 Pharmacodynamic properties

 

Sterculia acts in the colon by forming a soft bulky stool and inducing a laxative effect. Frangula acts as a mild peristaltic stimulant and aids the evacuation of the softened faecal mass.

 

 

5.2 Pharmacokinetic properties

 

Sterculia is not absorbed in the gastrointestinal tract; Frangula acts locally on the wall of the intestinal tract. The laxative action of NORMACOL PLUS is normally effective within 12 hours of oral administration.

 

 

5.3 Preclinical safety data

 

There are no preclinical data of relevance to the prescribed except as already included in the SPC.

 

 

6. PHARMACEUTICAL PARTICULARS

     

6.1 List of excipients

 

Sucrose

Talc

Sodium hydrogen carbonate

Paraffin wax

Peppermint flavouring

Indigo carmine (E132)

Erythrosine (E127)

Sunset yellow (E110)

Sodium chloride

 

 

6.2 Incompatibilities

 

None known.

 

 

6.3 Shelf life

 

Sachet and lined carton: 2 years.

 

 

6.4 Special precautions for storage

 

Sachet: Do not store above 25°C. Store in original package in a dry place.

Carton: Do not store above 25°C. Store in original package in a dry place. Keep the carton tightly closed.

 

 

6.5 Nature and contents of container

 

Sachet: Laminate consisting of 4 layers of low density polyethylene; aluminium; low density polyethylene and paper.

Each sachet contains 7 g of brown granules in boxes of 2, 7, or 60 sachets.

Lined carton: Laminate consisting of 4 layers of low density polyethylene; aluminium; low density polyethylene and paper.

Lined carton of 200 g or 500 g of brown granules.

Not all pack sizes may be marketed

 

 

6.6 Special precautions for disposal and other handling

 

No special requirements.

 

 

7. MARKETING AUTHORISATION HOLDER

 

Norgine Limited

Chaplin House

Widewater Place

Moorhall Road

Harefield

UXBRIDGE

Middlesex UB9 6NS

United Kingdom

 

 

8. MARKETING AUTHORISATION NUMBER(S)

 

PA 102/12/1

 

9. DATE OF FIRST AUTHORISATION/RENEWAL/RENEWAL OF AUTHORISATION

25 September 1984/ 25th September 2004

 

 

10. DATE OF REVISION OF THE TEXT

 

Date revised: November 2006

以下是“全球医药”详细资料
Tags: 责任编辑:admin
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Imbruvica 140 mg hard capsules 下一篇NORMACOL Granules.Sterculia

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位